Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Abbott Molecular Inc patents


Recent patent applications related to Abbott Molecular Inc. Abbott Molecular Inc is listed as an Agent/Assignee. Note: Abbott Molecular Inc may have other listings under different names/spellings. We're not affiliated with Abbott Molecular Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Abbott Molecular Inc-related inventors


Systems and methods for detection of genomic copy number changes

The present invention relates to systems and methods for detecting genomic copy number changes. In particular, the present invention relates to next generation sequencing methods for detection of copy number changes.. ... Abbott Molecular Inc

Detection of single nucleotide polymorphisms in human kras

Disclosed herein are primers and probes for the detection of single nucleotide polymorphisms (snps) in the kras gene. These primers and probes may be used in a method of identifying the presence or absence of one or more snps in the kras gene. ... Abbott Molecular Inc

Microorganism nucleic acid purification from host samples

The present disclosure provides systems, devices, and methods for purifying microorganism nucleic acid from a host sample, such as a whole blood sample from a human. In certain embodiments, devices and systems with multiple filters are employed and provide for the selective removal of blood cells and host nucleic acids from a sample in order to enrich for microorganism nucleic acid.. ... Abbott Molecular Inc

Enrichment of small nucleic acids

Provided herein is technology related to processing samples of nucleic acids and particularly, but not exclusively, to methods for enriching samples for small nucleic acids, such as small circulating cell-free dna.. . ... Abbott Molecular Inc

Maximizing dna yield of blood specimens collected in rapid clot tubes

The invention provides methods for isolating dna from a blood sample collected into tubes containing a rapid clot activator, which involves the use of a lysis buffer comprising an alcohol.. . ... Abbott Molecular Inc

Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples

The present invention relates to primers, probes, primer sets, primer and probe sets, methods and kits for detecting human papillomaviruses, human beta globin sequences and human papillomaviruses and human beta globin sequences in a test sample.. . ... Abbott Molecular Inc

Minimizing errors using uracil-dna-n-glycosylase

Provided herein is technology relating to enzymatic modification of nucleic acids and particularly, but not exclusively, to methods and compositions relating to using uracil-dna-n-glycosylase for minimizing or eliminating errors in a dna sequence due to deamination of cytosine residues.. . ... Abbott Molecular Inc

One-step procedure for the purification of nucleic acids

The present invention is a new and non-obvious method for the improved and simplified purification of nucleic acids.. . ... Abbott Molecular Inc

Compositions and methods for detecting zika virus

The invention is directed to compositions, kits, and methods for amplifying and detecting a zika virus nucleic acid sequence in a sample, which comprises a variety of combinations of forward oligonucleotide primers, reverse oligonucleotide primers, and oligonucleotide probes.. . ... Abbott Molecular Inc

Target sequence enrichment

The present invention provides methods, systems, kits, and compositions for magnetically purifying target nucleic acid sequences from a sample using bait molecules configured to bind both target nucleic acid sequences and magnetic binding particles. In certain embodiments, the bait molecules comprise a short target capture sequence (e.g., 18 to 48 bases), and the methods employ a short hybridization time (e.g., 1-4 hours) and a low hybridization temperature (e.g., about room temperature).. ... Abbott Molecular Inc

Multiplex methylation-specific amplification systems and methods

The present invention relates to systems and methods for performing multiplex amplification reactions. In particular, the present invention relates to multiplex methylation-specific amplification systems and methods.. ... Abbott Molecular Inc

Hybridization buffers

Disclosed herein are hybridization buffer compositions and hybridization compositions, methods of making the compositions, and methods of using the compositions, such as the hybridization of dna or rna sequences by fluorescence in situ hybridization (“fish”).. . ... Abbott Molecular Inc

Materials and methods for diagnosis, prognosis and assessment of therapeutic/prophylactic treatment of prostate cancer

A method to detect prostate cancer comprising contacting a sample of prostate cells from the patient with a set of detectably labeled probes under hybridization conditions and determining the presence of chromosomal abnormalities in prostate tumor tissue, pin (intra-epithelial neoplasia), histologically benign tissue and benign prostatic hyperplasia (bph); a method to combine immunofluorescence and fish (if-fish) to facilitate the assessment of chromosomal abnormalities; a set of probes; and a kit comprising the set of probes and instructions for diagnosing prostate cancer in a patient.. . ... Abbott Molecular Inc

Method and compositions for detecting epidermal growth factor receptor variant forms in cancer cells

Method and compositions for screening for the presence of epidermal growth factor receptor variant 3 (egfr(v3)) in a sample are described. The method comprises obtaining a sample containing a plurality of cells; hybridizing a set of chromosomal probes to the sample, wherein the set comprises an egfr(v3)-probe and a probe to chromosome 7 different from an egfr(v3)-probe; and visualizing the hybridization pattern of the set of chromosomal probes in the plurality of cells of the sample, wherein the presence of at least one copy of chromosome 7 lacking a hybridization signal of the egfr(v3)-probe in at least one cell is indicative of the presence of the egfr(v3) in the sample. ... Abbott Molecular Inc

04/06/17 / #20170096714

Detection of chromosomal abnormalities associated with prognosis of non small cell lung cancer

The methods and compositions described herein address the need for a diagnostic method that can be provided to patients with early stage lung cancer, especially non-small cell lung cancer (nsclc), to determine whether the patient is at increased risk of poor disease outcome. The methods and compositions thus allow for more informed treatment decisions for the early stage lung cancer patient.. ... Abbott Molecular Inc

03/23/17 / #20170081655

Purification of nucleic acids using copper-titanium oxides

The present disclosure relates to systems and methods for purifying nucleic acid. In particular, the present disclosure relates to systems and methods for purifying nucleic acids using metal or metal oxide compositions.. ... Abbott Molecular Inc

03/09/17 / #20170067126

Materials and methods for diagnosis of malignant melanoma and prognosis of metastasis of malignant melanoma

Methods, probes and kits for diagnosing malignant melanoma and prognosing metastasis thereof in a patient.. . ... Abbott Molecular Inc

03/09/17 / #20170067094

Hybridization buffers

Disclosed herein are hybridization buffer compositions and hybridization compositions, methods of making the compositions, and methods of using the compositions, such as the hybridization of dna or rna sequences by fluorescence in situ hybridization (“fish”) and blot hybridization methodologies.. . ... Abbott Molecular Inc

02/16/17 / #20170044594

Compositions and methods for identifying drug resistant tuberculosis

Provided herein are compositions and methods for diagnosing and characterizing tuberculosis infection. In particular, provided herein are compositions and methods for identifying drug resistant tuberculosis.. ... Abbott Molecular Inc

02/02/17 / #20170029806

Compositions and methods for nucleic acid extraction

Compositions and methods for the efficient extraction, enrichment and isolation of nucleic acids from fresh, fixed or fixed and embedded cells, tissues, biological materials and cellular source material.. . ... Abbott Molecular Inc

01/12/17 / #20170009223

Compositions and methods for nucleic acid extraction

Compositions and methods for the efficient extraction, enrichment and isolation of nucleic acids from fresh, fixed or fixed and embedded cells, tissues, biological materials and cellular source material.. . ... Abbott Molecular Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Abbott Molecular Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Abbott Molecular Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###